Pique Therapeutics, Inc. — Form D
Pique Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-19. The offering totals $1000K, of which $854K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-19
- Form: D
- Accession: 0001465515-18-000001
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $1000K
- Amount sold: $854K
- Remaining: $146K
- Minimum investment: $5K
- Investors: 13
- Date of first sale: 2017-07-31
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-328478
Issuer
- Name: Pique Therapeutics, Inc.
- CIK: 0001465515
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2005
- Address: 2530 MERIDIAN PARKWAY, DURHAM, NC, 27713
- Phone: 919-806-4395
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| John B Brennan | Director | Greensboro, NC |
| Keith Dionne | Director | Belmont, MA |
| Christopher Meldrum | Director | Durham, NC |
| Ian J Mehr | Executive Officer | Raliegh, NC |
| Christopher Meldrum | Executive Officer | Durham, NC |
Other filings by this issuer (1)
More